platinum has been researched along with 1-butyl-3-methylimidazolium in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Amende, M; Happel, M; Laurin, M; Libuda, J; Paape, N; Sobota, M; Wasserscheid, P | 1 |
| Karimi, F; Karimi-Maleh, H; Moradi, R; Shakeri, S; Shojaei, AF; Tabatabaeian, K | 1 |
2 other study(ies) available for platinum and 1-butyl-3-methylimidazolium
| Article | Year |
|---|---|
Ligand effects in SCILL model systems: site-specific interactions with Pt and Pd nanoparticles.
Topics: Carbon Monoxide; Catalysis; Imidazoles; Ionic Liquids; Ligands; Metal Nanoparticles; Models, Chemical; Palladium; Platinum; Spectrophotometry, Infrared | 2011 |
Simultaneous determination of 6-mercaptopruine, 6-thioguanine and dasatinib as three important anticancer drugs using nanostructure voltammetric sensor employing Pt/MWCNTs and 1-butyl-3-methylimidazolium hexafluoro phosphate.
Topics: Antineoplastic Agents; Complex Mixtures; Conductometry; Dasatinib; Equipment Design; Equipment Failure Analysis; Humans; Imidazoles; Mercaptopurine; Metal Nanoparticles; Nanotubes, Carbon; Platinum; Reproducibility of Results; Sensitivity and Specificity; Thioguanine | 2016 |